Neuritis óptica desmielinizante tras tratamiento con Infliximab

  1. A. Bidaguren
  2. A. Müller-Thyssen
  3. A. Blanco
  4. J. Mendicute
  5. M. Úbeda
Journal:
Archivos de la Sociedad Española de Oftalmologia

ISSN: 0365-6691

Year of publication: 2007

Volume: 82

Issue: 2

Pages: 109-112

Type: Article

DOI: 10.4321/S0365-66912007000200009 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Archivos de la Sociedad Española de Oftalmologia

Sustainable development goals

Abstract

Case report: We report the case of a 76-year-old woman who attended our hospital because of a sudden loss of visual acuity in her left eye. The problem appeared to be that of retrobulbar optic neuritis. However, the age of the patient together with the simultaneous use of Infliximab to treat her rheumatoid arthritis, suggests the demyelination may have been associated with the Infliximab use. Discussion: TNFalpha inhibitors (including Infliximab) are associated with demyelinating diseases including optic neuritis.

Bibliographic References

  • Foroozan, R, Buono, LM, Sergott, RC, Savino, PJ. (2002). Retrobulbar optic neuritis associated with infliximab. Arch Ophthalmol. 120. 985-987
  • van Oosten, BW, Barkhof, F, Truyen, L, Boringa, JB, Bertelsman, FW. (1996). Increased MRI activity and inmune reaction in two multiple esclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology. 47. 1531-1534
  • (1995). TNF neutralization in MS: Results of a randomized, placebo-controled multicenter study. Neurology. 53. 457-465
  • Strong, BY, Enry, BC, Herzenberg, H, Razzeca, KJ. (2004). Retrobulbar optic neuritis associated with Infliximab in a patient with Crohn Disease. Ann Intern Med. 20. 140678
  • Rebolleda, G. (2004). Infliximab y neuritis óptica. Arch Soc Esp Oftalmol. 79. 591
Data source: Dialnet